Abstract
BackgroundRandomized clinical trials have failed to prove that the safety and efficacy of endovascular treatment for symptomatic intracranial atherosclerotic disease (ICAD) is better than that of medical management. A recent...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have